Earnings Call Summary | SenesTech(SNES.US) Q1 2024 Earnings Conference
Earnings Call Summary | SenesTech(SNES.US) Q1 2024 Earnings Conference
The following is a summary of the SenesTech, Inc. (SNES) Q1 2024 Earnings Call Transcript:
以下是SenesTech, Inc.（SNES）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
SenesTech reported Q1 2024 revenue of $415,000, a 78% increase compared to Q1 2023.
Despite higher costs due to a supply chain issue, the operating expenses decreased by 8% to $2 million.
The company reported a net loss of $1.8 million in Q1 2024, an improvement of $200,000 from Q1 2023.
They aim to further reduce their annual operating expenses by $1 million in 2024.
SenesTech報告稱，2024年第一季度收入爲41.5萬美元，與2023年第一季度相比增長了78％。
儘管供應鏈問題導致成本增加，但運營費用下降了8％，至200萬美元。
該公司報告稱，2024年第一季度淨虧損180萬美元，比2023年第一季度增長20萬美元。
他們的目標是在2024年進一步將年度運營支出減少100萬美元。
Business Progress:
業務進展：
SenesTech successfully launched a new product, Evolve, which accounted for over half of their Q1 2024 revenue.
With efficacy studies now completed, Evolve is expected to receive approval in more states.
The introduction of Evolve Mouse doubled the market opportunity and is anticipated to drive growth throughout the year.
SenesTech is also seeing substantial interest internationally through their six-channel distribution strategy.
Their product, Evolve, plays a significant role in the financial growth and expansion plans for 2024.
SenesTech成功推出了一款名爲Evolve的新產品，該產品佔其2024年第一季度收入的一半以上。
隨着功效研究的完成，Evolve有望獲得更多州的批准。
Evolve Mouse的推出使市場機會翻了一番，預計將推動全年增長。
通過其六渠道分銷戰略，SenesTech也引起了國際上的濃厚興趣。
他們的產品Evolve在2024年的財務增長和擴張計劃中起着重要作用。
More details: SenesTech IR
更多詳情： SenesTech IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。